28 01/01/2024 31/12/2024 2024-12-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2024-01-01 Sage Accounts Production 24.0 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 00535531 2024-01-01 2024-12-31 00535531 2024-12-31 00535531 2023-12-31 00535531 2023-01-01 2023-12-31 00535531 2023-12-31 00535531 2022-12-31 00535531 core:PlantMachinery 2024-01-01 2024-12-31 00535531 core:FurnitureFittingsToolsEquipment 2024-01-01 2024-12-31 00535531 core:MotorVehicles 2024-01-01 2024-12-31 00535531 core:NetGoodwill 2024-01-01 2024-12-31 00535531 bus:LeadAgentIfApplicable 2024-01-01 2024-12-31 00535531 bus:Director2 2024-01-01 2024-12-31 00535531 bus:Director3 2024-01-01 2024-12-31 00535531 core:NetGoodwill 2024-12-31 00535531 core:LandBuildings core:OwnedOrFreeholdAssets 2023-12-31 00535531 core:LandBuildings core:ShortLeaseholdAssets 2023-12-31 00535531 core:FurnitureFittingsToolsEquipment 2023-12-31 00535531 core:MotorVehicles 2023-12-31 00535531 core:LandBuildings core:OwnedOrFreeholdAssets 2024-12-31 00535531 core:LandBuildings core:ShortLeaseholdAssets 2024-12-31 00535531 core:FurnitureFittingsToolsEquipment 2024-12-31 00535531 core:MotorVehicles 2024-12-31 00535531 core:WithinOneYear 2024-12-31 00535531 core:WithinOneYear 2023-12-31 00535531 core:AfterOneYear 2024-12-31 00535531 core:AfterOneYear 2023-12-31 00535531 core:RetainedEarningsAccumulatedLosses 2023-01-01 2023-12-31 00535531 core:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 00535531 core:ShareCapital 2024-12-31 00535531 core:ShareCapital 2023-12-31 00535531 core:RetainedEarningsAccumulatedLosses 2024-12-31 00535531 core:RetainedEarningsAccumulatedLosses 2023-12-31 00535531 core:ShareCapital 2022-12-31 00535531 core:RetainedEarningsAccumulatedLosses 2022-12-31 00535531 core:PreviouslyStatedAmount core:ShareCapital 2024-12-31 00535531 core:LandBuildings core:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 00535531 core:LandBuildings core:ShortLeaseholdAssets 2024-01-01 2024-12-31 00535531 core:NetGoodwill 2023-12-31 00535531 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 00535531 core:Non-currentFinancialInstruments 2024-12-31 00535531 core:Non-currentFinancialInstruments 2023-12-31 00535531 core:LandBuildings core:OwnedOrFreeholdAssets 2023-12-31 00535531 core:LandBuildings core:ShortLeaseholdAssets 2023-12-31 00535531 core:FurnitureFittingsToolsEquipment 2023-12-31 00535531 core:MotorVehicles 2023-12-31 00535531 bus:Director2 2023-12-31 00535531 bus:Director2 2024-12-31 00535531 bus:Director3 2023-12-31 00535531 bus:Director3 2024-12-31 00535531 bus:Director2 2022-12-31 00535531 bus:Director2 2023-12-31 00535531 bus:Director3 2022-12-31 00535531 bus:Director3 2023-12-31 00535531 bus:Director2 2023-01-01 2023-12-31 00535531 bus:SmallEntities 2024-01-01 2024-12-31 00535531 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 00535531 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 00535531 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 00535531 bus:FullAccounts 2024-01-01 2024-12-31
Company registration number: 00535531
Ackers (Chemists) Limited
Unaudited filleted financial statements
31 December 2024
Ackers (Chemists) Limited
Contents
Accountants report
Statement of financial position
Statement of changes in equity
Notes to the financial statements
Ackers (Chemists) Limited
Report to the board of directors on the preparation of the
unaudited statutory financial statements of Ackers (Chemists) Limited
Year ended 31 December 2024
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Ackers (Chemists) Limited for the year ended 31 December 2024 which comprise the statement of financial position, statement of changes in equity and related notes from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Association of Chartered Certified Accountants , we are subject to its ethical and other professional requirements which are detailed at http://www.accaglobal.com/en/member/ professional-standards/ rules-standards/acca-rulebook.html.
This report is made solely to the board of directors of Ackers (Chemists) Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Ackers (Chemists) Limited and state those matters that we have agreed to state to the board of directors of Ackers (Chemists) Limited as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at https://www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/tf-163-jan-24.pdf. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Ackers (Chemists) Limited and its board of directors as a body for our work or for this report.
It is your duty to ensure that Ackers (Chemists) Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Ackers (Chemists) Limited. You consider that Ackers (Chemists) Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of Ackers (Chemists) Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Hindocha Pandit & Co Limited
Chartered Certified Accountants
34 Queensbury Station Parade
Edgware
Middlesex
HA8 5NN
28 April 2025
Ackers (Chemists) Limited
Statement of financial position
31 December 2024
2024 2023
Note £ £ £ £
Fixed assets
Intangible assets 5 468,214 468,214
Tangible assets 6 478,043 517,098
Investments 7 72 72
_______ _______
946,329 985,384
Current assets
Stocks 726,559 785,080
Debtors 8 705,742 530,781
Cash at bank and in hand 367,218 735,953
_______ _______
1,799,519 2,051,814
Creditors: amounts falling due
within one year 9 ( 1,479,310) ( 1,580,614)
_______ _______
Net current assets 320,209 471,200
_______ _______
Total assets less current liabilities 1,266,538 1,456,584
Creditors: amounts falling due
after more than one year 10 ( 8,611) ( 25,595)
_______ _______
Net assets 1,257,927 1,430,989
_______ _______
Capital and reserves
Called up share capital 100 100
Profit and loss account 1,257,827 1,430,889
_______ _______
Shareholders funds 1,257,927 1,430,989
_______ _______
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 28 April 2025 , and are signed on behalf of the board by:
Mr R R Patel Mr H R Patel
Director Director
Ackers (Chemists) Limited
Statement of changes in equity
Year ended 31 December 2024
Called up share capital Profit and loss account Total
£ £ £
At 1 January 2023 100 1,696,248 1,696,348
Loss for the year ( 265,359) ( 265,359)
_______ _______ _______
Total comprehensive income for the year - ( 265,359) ( 265,359)
_______ _______ _______
At 31 December 2023 and 1 January 2024 100 1,430,889 1,430,989
Loss for the year ( 173,062) ( 173,062)
_______ _______ _______
Total comprehensive income for the year - ( 173,062) ( 173,062)
_______ _______ _______
At 31 December 2024 100 1,257,827 1,257,927
_______ _______ _______
Ackers (Chemists) Limited
Notes to the financial statements
Year ended 31 December 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Ackers (Chemists) Limited, 94 Church Road, Swanscombe, Kent, DA10 0HF.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Operating leases
Lease payments are recognised as an expense over the lease term on a straight-line basis. The aggregate benefit of lease incentives is recognised as a reduction to expense over the lease term, on a straight-line basis.
Goodwill
The accounting policy of the company is to capitalise purchased goodwill. In the director's opinion the value of goodwill has been maintained and therefore in order that the financial statements to give a true and fair view they consider it inappropriate to amortise its value.
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Tangible assets
tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Short leasehold property - Straight line over the life of the lease
Plant and machinery - 15% % reducing balance
Fittings fixtures and equipment - 15% % reducing balance
Motor vehicles - 25% % reducing balance
If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.
Fixed asset investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses. Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised in finance costs in profit or loss in the period in which it arises.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 28 (2023: 28 ).
5. Intangible assets
Goodwill Total
£ £
Cost
At 1 January 2024 and 31 December 2024 468,214 468,214
_______ _______
Amortisation
At 1 January 2024 and 31 December 2024 - -
_______ _______
Carrying amount
At 31 December 2024 468,214 468,214
_______ _______
At 31 December 2023 468,214 468,214
_______ _______
6. Tangible assets
Freehold property Short leasehold property Fixtures, fittings and equipment Motor vehicles Total
£ £ £ £ £
Cost
At 1 January 2024 37,931 734,003 502,963 10,200 1,285,097
Additions - - 5,000 - 5,000
_______ _______ _______ _______ _______
At 31 December 2024 37,931 734,003 507,963 10,200 1,290,097
_______ _______ _______ _______ _______
Depreciation
At 1 January 2024 2,991 336,660 418,634 9,712 767,997
Charge for the year 1,496 29,382 12,962 217 44,057
_______ _______ _______ _______ _______
At 31 December 2024 4,487 366,042 431,596 9,929 812,054
_______ _______ _______ _______ _______
Carrying amount
At 31 December 2024 33,444 367,961 76,367 271 478,043
_______ _______ _______ _______ _______
At 31 December 2023 34,940 397,343 84,329 488 517,100
_______ _______ _______ _______ _______
7. Investments
Other investments other than loans Total
£ £
Cost
At 1 January 2024 and 31 December 2024 72 72
_______ _______
Impairment
At 1 January 2024 and 31 December 2024 - -
_______ _______
Carrying amount
At 31 December 2024 72 72
_______ _______
At 31 December 2023 72 72
_______ _______
8. Debtors
2024 2023
£ £
Trade debtors 372,638 340,142
Amounts owed by group undertakings and undertakings in which the company has a participating interest 203,966 46,863
Other debtors 129,138 143,776
_______ _______
705,742 530,781
_______ _______
9. Creditors: amounts falling due within one year
2024 2023
£ £
Bank loans and overdrafts 8,333 8,333
Trade creditors 619,545 738,496
Social security and other taxes 17,797 16,205
Other creditors 833,635 817,580
_______ _______
1,479,310 1,580,614
_______ _______
10. Creditors: amounts falling due after more than one year
2024 2023
£ £
Bank loans and overdrafts 8,611 25,595
_______ _______
11. Directors advances, credits and guarantees
During the year the directors entered into the following advances and credits with the company:
2024
Balance brought forward Advances /(credits) to the directors Amounts repaid Balance o/standing
£ £ £ £
Mr R R Patel ( 494,459) ( 28,000) 12,526 ( 509,933)
Mr H R Patel ( 302,337) - - ( 302,337)
_______ _______ _______ _______
( 796,796) ( 28,000) 12,526 ( 812,270)
_______ _______ _______ _______
2023
Balance brought forward Advances /(credits) to the directors Amounts repaid Balance o/standing
£ £ £ £
Mr R R Patel ( 472,997) ( 28,000) 6,538 ( 494,459)
Mr H R Patel ( 302,337) - - ( 302,337)
_______ _______ _______ _______
( 775,334) ( 28,000) 6,538 ( 796,796)
_______ _______ _______ _______
12. Related party transactions
During the year the company entered into the following transactions with related parties:
Transaction value
2024 2023
£ £
Springate & Harrison Limited - Management Fees - -
Springate & Harrison Limited - Intercompany Sales & Recharges 514,347 469,909
_______ _______
During the year company also sold pharmaceutical products and recharges of costs and services to the value of £514,347 to its holding company Springate & Harrison Limited. All transactions have been on a commercial basis.
13. Ultimate parent undertaking
The company is a wholly owned subsidiary of Springate & Harrison Limited, incorporated in England and regards it as its ultimate holding company. During the year Springate & Harrison Limited was under the control of it's directors Mr R R Patel and Mr H R Patel .